Diagnostyka (WAR:DIA) Other Long-Term Liabilities: zł44 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:DIA Diagnostyka SA WAR:DIA
15 GF Score
Price zł161.60
! 2 Warning Signs
View Full Analysis

What is Diagnostyka Other Long-Term Liabilities?

Diagnostyka WAR:DIA -1.70% 15 Other Long-Term Liabilities is zł44 Mil as of Jun. 2026. GuruFocus rates WAR:DIA with a GF Score™ of 15/100. The stock has 2 warning signs investors should review.

Diagnostyka's other long-term liabilities for the quarter that ended in Jun. 2026 was zł44 Mil.

Diagnostyka's quarterly other long-term liabilities declined from Dec. 2025 (zł55 Mil) to Mar. 2026 (zł35 Mil) but then increased from Mar. 2026 (zł35 Mil) to Jun. 2026 (zł44 Mil).

Diagnostyka's annual other long-term liabilities increased from Dec. 2023 (zł7 Mil) to Dec. 2024 (zł40 Mil) and increased from Dec. 2024 (zł40 Mil) to Dec. 2025 (zł55 Mil).

Diagnostyka Other Long-Term Liabilities Related Terms

Diagnostyka Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Diagnostyka's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnostyka Other Long-Term Liabilities Chart

Diagnostyka Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
3.06 3.78 6.75 40.27 54.77

Diagnostyka Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 47.99 53.34 54.77 35.43 43.61
WAR:DIA
15GF Score
Diagnostyka SA WAR:DIA
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnostyka Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of zł44 Mil mean?
Diagnostyka (WAR:DIA) has a Other Long-Term Liabilities of zł44 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Diagnostyka and its competitors.
Is Diagnostyka's Other Long-Term Liabilities too high?
Diagnostyka's current Other Long-Term Liabilities is zł44 Mil. Overall, Diagnostyka has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Diagnostyka's Other Long-Term Liabilities compare to TMO and DHR?
Diagnostyka's Other Long-Term Liabilities of zł44 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Diagnostics & Research company?
A good Other Long-Term Liabilities depends on the Medical Diagnostics & Research industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Diagnostyka and its competitors. Diagnostyka's current Other Long-Term Liabilities is zł44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostyka stock overvalued right now?
Diagnostyka (WAR:DIA) has a current Other Long-Term Liabilities of zł44 Mil. The current Other Long-Term Liabilities is zł44 Mil. Diagnostyka's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Diagnostyka (WAR:DIA), the current Other Long-Term Liabilities is zł44 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diagnostyka Business Description

Other Exchanges 7JS:Germany
Address Ul. Prof. Michala Zyczkowskiego 16, Krakow, POL, 31-864
Diagnostyka SA is engaged in providing laboratory diagnostics services in Poland. The company offers comprehensive laboratory services from collecting biological material, through testing, to providing results online.
15GF Score

Get the complete analysis for WAR:DIA

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł161.60
Price